We invite you to a series of seminars on medicinal products. Safety stock – the biggest intervention in the marketing of medicines and the obligation to supply the market is approaching, we will tell you what will need to be done, when and how, we will discuss prices and reimbursement of medicines, what the new requirements for VILP and Orphans have brought, what is emerging in the proceedings before the SÚKL, what will be the changes in the Price Regulation for 2024, what changes may be brought by the upcoming amendment 48. And more.
